The card pairs with the Ortho Vision Platform to provide a complete gel-based DAT solution for transfusion medicine laboratories.
The US Food and Drug Administration has cleared QuidelOrtho’s Micro Typing Systems (MTS) DAT Card, completing the company’s gel-based solution for direct antiglobulin testing in transfusion medicine laboratories.
The MTS DAT Card works with QuidelOrtho’s Ortho Vision Platform, combining column agglutination technology with software capabilities including reflex testing and as-needed quality control. The system is designed to help laboratories deliver faster results for patients requiring transfusion decisions.
QuidelOrtho announced the clearance alongside its participation in the Association for the Advancement of Blood & Biotherapies (AABB) 2025 Annual Meeting, where the company is showcasing its transfusion medicine portfolio.
“Our participation reinforces our dedication to driving innovation that advances laboratory performance and enhances efficiency, helping to improve patient outcomes worldwide,” says Michelle Mullens, global product manager, portfolio solutions transfusion medicine at QuidelOrtho, in a release.
Platform Features and Capabilities
The Ortho Vision Platform includes two analyzer options for different laboratory throughput needs. The Ortho Vision Max Swift Analyzer targets high-throughput laboratories with expanded capacity for samples and reagents, while the Ortho Vision Swift Analyzer offers walkaway automation with reported 98% uptime using ID-MTS Gel Test technology.
The platform integrates with Ortho Connect Lab Management Software, which provides middleware for lab networks to streamline operations and address compliance requirements.
Educational Content at AABB
QuidelOrtho is presenting educational sessions and poster presentations at the AABB meeting covering topics including Rh(D) antigen identification challenges, gel testing applications for patients treated with daratumumab, and advanced immunohematology techniques for complex serological cases.
The company’s poster presentations focus on gel card evaluation for detecting IgG and C3, as well as instrumentation reliability metrics for immunohematology testing in transfusion medicine laboratories.
Direct antiglobulin testing is used to detect antibodies or complement proteins bound to red blood cells, helping diagnose conditions such as autoimmune hemolytic anemia and investigating transfusion reactions.
ID 138733496 | Blood Test © Ivan Shidlovski | Dreamstime.com
